Coronavirus Vaccine

The Chinese authorities are rushing to push out vaccines to combat an ongoing new wave of the coronavirus that is expected to peak in June and infect as many as 65 million people a week.

After more than three years, the global Covid emergency is officially over.

India has logged 3,962 new coronavirus infections, while the active cases have decreased to 36,244 from 40,177, according to the Union Health Ministry data updated on Thursday.

India has recorded 3,720 new COVID-19 infections and the count of active cases of the disease in the country stands at 40,177, according to Union Health Ministry data updated on Wednesday.

There's a 27.5% chance a pandemic as deadly as Covid-19 could take place in the next decade as viruses emerge more frequently, with rapid vaccine rollout the key to reducing fatalities, according to a predictive health analytics firm.

With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.

Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.

Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.

iNCOVACC, the world's first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India's Bharat Biotech.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

Novak Djokovic said "it is what it is" Thursday as he faced the prospect of missing more tournaments in the United States over his refusal to have a coronavirus shot

Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.

Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

The Chinese authorities are rushing to push out vaccines to combat an ongoing new wave of the coronavirus that is expected to peak in June and infect as many as 65 million people a week.

After more than three years, the global Covid emergency is officially over.

India has logged 3,962 new coronavirus infections, while the active cases have decreased to 36,244 from 40,177, according to the Union Health Ministry data updated on Thursday.

India has recorded 3,720 new COVID-19 infections and the count of active cases of the disease in the country stands at 40,177, according to Union Health Ministry data updated on Wednesday.

There's a 27.5% chance a pandemic as deadly as Covid-19 could take place in the next decade as viruses emerge more frequently, with rapid vaccine rollout the key to reducing fatalities, according to a predictive health analytics firm.

With more than 100 cases of coronavirus being reported in Odisha for four days now, the state government Tuesday requested the Centre for at least an additional 50,000 doses of vaccine.

Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.

Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.

iNCOVACC, the world's first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India's Bharat Biotech.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.

Novak Djokovic said "it is what it is" Thursday as he faced the prospect of missing more tournaments in the United States over his refusal to have a coronavirus shot

Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.

Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.